Annual Drug Patent Expirations for VARITHENA Varithena is a drug marketed by Provensis and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent expiration for Provensis drug VARITHENA appeare…
New patent expiration for Provensis drug VARITHENA Read Post »
Annual Drug Patent Expirations for QSYMIA Qsymia is a drug marketed by Vivus and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for VIVUS drug QSYMIA appeared first on DrugPatentWatch – …
This chart shows the pharmaceutical companies with the most patents in United Kingdom. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical companies have the most drug …
Which pharmaceutical companies have the most drug patents in United Kingdom? Read Post »
Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
New tentative approval for Eugia Pharma drug palbociclib Read Post »
Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
New tentative approval for Eugia Pharma drug palbociclib Read Post »
This chart shows the pharmaceutical drugs with the greatest number of patents still in force. The number of patents covering a drug can be indicative of the value of a…
The post Which pharmaceutical drugs have the most patents? appeared first on DrugPa…
Which pharmaceutical drugs have the most patents? Read Post »
Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
New tentative approval for Eugia Pharma drug palbociclib Read Post »
Annual Drug Patent Expirations for AXID Axid is a drug marketed by Smithkline Beecham, Braintree, and Glaxosmithkline and, and is included in three NDAs. There is one patent protecting this…
The post New patent expiration for Braintree drug AXID appear…
This chart shows the drugs with the most patents in Taiwan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Taiwan? …
Which pharmaceutical drugs have the most drug patents in Taiwan? Read Post »
Annual Drug Patent Expirations for VOSEVI Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are eighteen…
The post New patent for Gilead Sciences drug VOSEVI appeared first on DrugPate…
Get new actionable insights and updates from BiotechBlog
